ROBERT SAUNDERS

Profile

First Name

: ROBERT

Middle Name

:

Last Name

: SAUNDERS

Related Companies
Titles
Company Name
Related People
DIRECTOR
TECHSKILLS LLC
MARC BERMAN, STEVE DELCARSON, JAMES DUGAN, TOM JENKINS, DAVID JONES, JR., JASON MAHONEY, DAVID PARENTO, KEVIN PAULSEN, JOHN POLAND, WRIGHT STEENROD, RICHARD VANCE
DIRECTOR
SS1 ACQUISITION, LLC
NIKHIL DEO, DAMON LANGE, TIMOTHY REILLY, TIM THOMAS
DIRECTOR
VIVORTE INC.
WILLIAM SCHEESSELE, MICHAEL VOOR, RUTH VOOR, MARK WAGNER, PETER WEISS, TYREE WILBURN
DIRECTOR
IF TECHNOLOGIES, INC
JAMES R FREEDMAN, JAMES R. FREEDMAN, PHILLIP M. ISSAC, PHILLIP MICHAEL ISSAC, WILLIAM H. LOMICKA, SEAN SMITH
DIRECTOR
DF DISTRESSED EQUITY PROPERTY FUND I, L.P.
MARK CRANE, MARK W. CRANE, BRANDON DENTON, GP, LLC DF, LLC DF GP,, TOMMY FLOYD, MIGUEL MONTANO
DIRECTOR
DF DISTRESSED MEZZANINE PROPERTY FUND I, L.P.
MARK CRANE, BRANDON DENTON, GP, LLC DF, TOMMY FLOYD, MIGUEL MONTANO
DIRECTOR
COBRA STYLET L.L.C.
FRANCIS DUQUE, JAMES E. GEISLER, DAVID Y. PHELPS, CHRISTOPHER P. RAND, BARRY SIMON, RICHARD TRONTZ
DIRECTOR
NX PHARMAGEN INC.
BRIAN BROHMAN, BRIAN D. BROHMAN, PASCAL DESCHATELETS, ALAN EZRIN, ALAN M. EZRIN, CEDRIC FRANCOIS, FRED MERMELSTEIN
EXECUTIVE OFFICER
ADVANCED RESOURCE TECHNOLOGIES (ART) LLC
JEFF FRANK, GREGORY P. MURDOCK
EXECUTIVE OFFICER, DIRECTOR
ADVANCED RESOURCE TECHNOLOGY DEVELOPMENT LLC
JEFF FRANK, JOHN GAENSBAUER, MARK LEONARD, GREGORY P. MURDOCK
EXECUTIVE OFFICER
OCA VENTURES III, L.P.
IAN DRURY, JAMES DUGAN, PETER IANELLO, DAVE ZYER
DIRECTOR
NX DEVELOPMENT CORP.
BRIAN BROHMAN, ALAN EZRIN, ALAN M EZRIN, FRED MERMELSTEIN, GREGORY MURDOCK
DIRECTOR
REGROUP THERAPY INC.
CHRISTOPER BOOKER, JULIAN COHEN, DAVID COHN, DAVID ANDREW COHN, JORDAN DOLIN, VINCENT FABIANI, THOMAS HALL, THOMAS JOSEPH HALL, JOHN HARRIS, KIM HILL, KIMBERLY HILL, GREG KRIS, GREGORY KRIS, MOON LEE, STANLEY LYNALL, JUSTINE MITCHELL, PHILIP PERKINS, SAPAN SHAH, JEFFRY TILLERY
DIRECTOR
NX PRENATAL INC.
DAVID ADAIR, KEVIN BRAMER, BRIAN BROHMAN, MARY LAKE POLAN, ALAN MACK, GAIL PAGE
DIRECTOR
SEIKOWAVE DENTAL, INC.
MATTHEW BELLIS, SHINICHIRO FUKUSHIGE, ROBERT HIRST, RICHARD MILLER, MINORU NIIMURA
DIRECTOR
PROGENTEC DIAGNOSTICS, INC.
MOHAN PURUSHOTHAMAN, SANJIV SHARMA
EXECUTIVE OFFICER
OCA VENTURES IV, L.P.
IAN DRURY, JAMES DUGAN, PETER IANELLO, TAMIM ABDUL MAJID
EXECUTIVE OFFICER
NOVEL COWORKING FUND III - A, LP
WILLIAM BENNETT, MATTHEW GOEBEL, N/A NOVEL COWORKING FUND III GP, LLC
EXECUTIVE OFFICER
NOVEL COWORKING FUND III - B, LP
WILLIAM BENNETT, MATTHEW GOEBEL, N/A NOVEL COWORKING FUND III GP, LLC
EXECUTIVE OFFICER
NOVEL COWORKING FUND III - I, LP
WILLIAM BENNETT, MATTHEW GOEBEL, N/A NOVEL COWORKING FUND III GP, LLC
DIRECTOR
SEIKOWAVE HEALTH SOLUTIONS, INC.
MATTHEW BELLIS, SHINICHIRO FUKUSHIGE, ROBERT HIRST, RICHARD MILLER, MINORU NIIMURA
DIRECTOR, EXECUTIVE OFFICER
EBLU SOLUTIONS, INC.
MICHAEL DAVIS, KIM FARLEY, NATHAN FORNWALT, THOMAS HEARN, LANCE HILL, ROGER KOBEL, MARK MURPHY, WILLIAM TRAINOR
DIRECTOR
AMOPPORTUNITIES, INC.
IMRAN AHMAD, MARK BAKKEN, CHARLES BOROM, BENJAMIN BRADLEY, DANIEL FLORES, KEVIN IVERSON, ROJEK KELLI, JULIA MONFRINI PEEV, KELLI ROJEK, BOB SAUNDERS, OUCH SEREIRATH, KYLE SWINSKY, JON DAVID WILLINGHAM, MALEK YALA
EXECUTIVE OFFICER
CA STUDENT LIVING INCOME + GROWTH, LP
ROBERT BEESLEY, STEVE BOYACK, N/A CA STUDENT LIVING INCOME AND GROWTH GP, LLC, N/A CASL INVESTMENT MANAGEMENT, LLC, CHENG CHEN, MICHAEL HALES, THIERRY KEABLE, JIM REILAND, DAVID ROSE, THOMAS SCOTT, J.J. SMITH, SEAN SPELLMAN
EXECUTIVE OFFICER
CA STUDENT LIVING INCOME + GROWTH FEEDER, LP
ROBERT BEESLEY, STEVE BOYACK, N/A CA STUDENT LIVING INCOME AND GROWTH GP, LLC, N/A CASL INVESTMENT MANAGEMENT, LLC, CHENG CHEN, MICHAEL HALES, THIERRY KEABLE, JIM REILAND, DAVID ROSE, THOMAS SCOTT, J.J. SMITH, SEAN SPELLMAN
EXECUTIVE OFFICER
CA STUDENT LIVING INCOME + GROWTH (PARALLEL), LP
ROBERT BEESLEY, STEVE BOYACK, N/A CA STUDENT LIVING INCOME AND GROWTH GP, LLC, N/A CASL INVESTMENT MANAGEMENT, LLC, CHENG CHEN, MICHAEL HALES, THIERRY KEABLE, JIM REILAND, DAVID ROSE, THOMAS SCOTT, J.J. SMITH, SEAN SPELLMAN
DIRECTOR
NEXOSOME ONCOLOGY HOLDINGS, INC.
BRIAN BROHMAN, MATTHEW DICKEN, ALAN EZRIN, TODD HEMBROUGH
DIRECTOR
CA STUDENT LIVING INVESTMENT FUND REIT, LLC
CHENG CHEN, THOMAS M. SCOTT, SEAN SPELLMAN
EXECUTIVE OFFICER
OCA VENTURES GROWTH FUND, L.P.
JAMES DUGAN, PETER IANELLO, TAMIM ABDUL MAJID
DIRECTOR
INNOVATIVE THERAPEUTIX, INC.
MICHAEL R. DETMER, REBEKAH GOSSOM
DIRECTOR, EXECUTIVE OFFICER
EBLU SOLUTIONS INC.
MICHAEL DAVIS, KIM FARLEY, NATHAN FORNWALT, THOMAS HEARN, LANCE HILL, ROGER KOBEL, MARK MURPHY, WILLIAM TRAINOR
DIRECTOR
AMPLIFIED SCIENCES, INC.
DIANA CALDWELL, DIANA T CALDWELL, ANDREW COTHREL, ANDREW D COTHREL, VINCENT J DAVISSON, VINCENT JO DAVISSON, WADE LANGE
DIRECTOR
DESICORP, INC.
BRETT JANIS, JONATHAN KOPECHECK, MICHAEL MENZE
DIRECTOR
EQL GAMES INC.
GREG BUONOCORE, MARK CRANE, BRADFORD CUMMINGS, MARK MUELLER, THOMAS MUELLER, GARY RUSSELL, SETH YOUNG
DIRECTOR
IPILL INC.
ARTHUR BECKER, TOBIAS FISCHLI, JOHN HSU, MICHELE LEONHART
EXECUTIVE OFFICER
OCA ROADRUNNER II, LLC
JAMES DUGAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-06
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2026-06-25 
2026-06-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-20 
2026-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-20 
2026-02-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-11 
2026-01-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-03 
2025-11-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-03 
2025-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-11 
2025-05-29
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-23 
2025-04-02
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-16 
2024-07-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2024-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2024-07-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-03 
2024-03-25
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2024-01-26
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2024-01-03
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2023-08-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-02 
2023-08-21
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-07 
2023-03-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2023-01-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2022-12-15 
2022-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-10 
2022-07-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-07 
2022-03-21
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-06-29 
2022-02-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2021-12-14 
2021-12-29
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
2021-11-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-05 
2021-10-27
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2019-08-07 
2021-10-27
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2019-08-07 
2021-10-27
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2019-08-07 
2021-10-21
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-08 
2021-08-04
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2021-04-09
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-31 
2021-03-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-26 
2021-01-11
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-13 
2020-12-11
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-11-25 
2020-11-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2020-11-16 
2020-09-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-28 
2020-09-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-15 
2020-08-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-17 
2020-07-15
D
Link
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-01 
2020-05-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-27 
2020-04-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-28 
2020-03-17
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2019-05-15 
2020-03-04
D
Link
POOLED INVESTMENT FUND 
 
 
Equity 
2020-02-18 
2020-03-04
D
Link
POOLED INVESTMENT FUND 
 
 
Equity 
2020-02-18 
2020-03-04
D
Link
POOLED INVESTMENT FUND 
 
 
Equity 
2020-02-18 
2019-11-15
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-08 
2019-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-07-05 
2018-11-29
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2017-09-19 
2018-11-29
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity, Debt 
2015-11-05 
2018-11-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-09 
2018-08-24
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-27 
2018-06-13
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-30 
2017-11-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-20 
2017-09-01
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-02 
2017-06-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-02 
2016-12-15
D
Link
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-30 
2016-05-27
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2016-05-16 
2015-10-28
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-10-28 
2013-07-25
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-12-30 
2013-06-25
D
Link
OTHER HEALTH CARE 
 
NO REVENUES 
Debt 
2013-06-24 
2013-04-30
D
Link
OTHER 
 
NO REVENUES 
Equity 
2013-03-27 
2013-04-29
D
Link
OTHER 
 
NO REVENUES 
Equity 
2012-10-10 
2012-09-05
D
Link
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2012-08-28 
2012-07-13
D
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2012-06-28 
2012-07-13
D
Link
RESIDENTIAL 
 
NO REVENUES 
Equity 
2012-06-28 
2011-05-17
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-06 
2011-01-19
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-12-30 
2009-06-15
D/A
Link
OTHER TECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2009-06-08 
2009-06-12
D
Link
OTHER TECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2009-06-08 
2009-03-26
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2009-02-05